In advanced stages of AD, AChE activity declines to approximately 10%–15% of normal levels, whereas BChE activity remains stable or may even increase up to 120% of baseline (Perry et al., 1978; Giacobini, 2004). This evidence concerns the gene ACHE and Alzheimer disease.